Viewing Study NCT00051220



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00051220
Status: COMPLETED
Last Update Posted: 2013-06-07
First Post: 2003-01-07

Brief Title: Treatment for Specific Phobias in Children
Sponsor: Virginia Polytechnic Institute and State University
Organization: Virginia Polytechnic Institute and State University

Study Overview

Official Title: One-Session Treatment for Specific Phobias in Children
Status: COMPLETED
Status Verified Date: 2013-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents
Detailed Description: Children with specific phobias may experience academic social and personal distress as well as interference in day-to-day activities One-Session Treatment has been found a rapid and effective treatment for adults with phobic disorders However its utility in the treatment of childhood phobia has not been examined

Participants are randomly assigned to 1 of 3 groups a one-session treatment group an educationsupport group and a waitlist control group The one-session treatment group is directly exposed to a phobia object or situation during a 3-hour treatment session In the educationsupport group children are given information about fear and phobias and are taught how to deal with them through workbook activities Children who participate in the one-session treatment group or the educationsupport group are assessed 1 week post-treatment and again after 6 months Participants with improved symptoms have a 1-year follow-up Participants with phobias that persist at 6 months are encouraged to participate in alternative treatment Waitlist control participants are assessed pre-treatment and 1 month post-treatment Those who continue to have phobias at the 1-month assessment are randomly assigned to 1 of the 2 active treatments

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DSIR CT-S US NIH GrantContract None httpsreporternihgovquickSearchR01MH059308
R01MH059308 NIH None None